BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30460633)

  • 1. Transcriptome profiling reveals PDZ binding kinase as a novel biomarker in peritumoral brain zone of glioblastoma.
    Kruthika BS; Jain R; Arivazhagan A; Bharath RD; Yasha TC; Kondaiah P; Santosh V
    J Neurooncol; 2019 Jan; 141(2):315-325. PubMed ID: 30460633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence.
    Nimbalkar VP; Kruthika BS; Sravya P; Rao S; Sugur HS; Verma BK; Chickabasaviah YT; Arivazhagan A; Kondaiah P; Santosh V
    J Neurooncol; 2021 Mar; 152(1):55-65. PubMed ID: 33389566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma.
    Kruthika BS; Sugur H; Nandaki K; Arimappamagan A; Paturu K; Santosh V
    J Clin Pathol; 2019 Oct; 72(10):677-681. PubMed ID: 31270134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.
    Dong C; Fan W; Fang S
    J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.
    Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Br J Cancer; 2017 Jan; 116(2):218-226. PubMed ID: 27898655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.
    Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profile of glioblastoma peritumoral tissue: an ex vivo study.
    Mangiola A; Saulnier N; De Bonis P; Orteschi D; Sica G; Lama G; Pettorini BL; Sabatino G; Zollino M; Lauriola L; Colabianchi A; Proietti G; Kovacs G; Maira G; Anile C
    PLoS One; 2013; 8(3):e57145. PubMed ID: 23472076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts.
    Leiss L; Mutlu E; Øyan A; Yan T; Tsinkalovsky O; Sleire L; Petersen K; Rahman MA; Johannessen M; Mitra SS; Jacobsen HK; Talasila KM; Miletic H; Jonassen I; Li X; Brons NH; Kalland KH; Wang J; Enger PØ
    BMC Cancer; 2017 Feb; 17(1):108. PubMed ID: 28173797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of primary and recurrent human glioblastoma multiforme using the small animal imaging and molecular expressive profiles.
    Lin LT; Chiou SH; Lee TW; Liu RS; Hwang JJ; Chang CH; Ma HI; Lee YJ
    Mol Imaging Biol; 2013 Jun; 15(3):262-72. PubMed ID: 22948536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma.
    Chen Q; Weng HY; Tang XP; Lin Y; Yuan Y; Li Q; Tang Z; Wu HB; Yang S; Li Y; Zhao XL; Fu WJ; Niu Q; Feng H; Zhang X; Wang Y; Bian XW; Yao XH
    J Pathol; 2019 Feb; 247(2):266-278. PubMed ID: 30357833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival kinase genes present prognostic significance in glioblastoma.
    Varghese RT; Liang Y; Guan T; Franck CT; Kelly DF; Sheng Z
    Oncotarget; 2016 Apr; 7(15):20140-51. PubMed ID: 26956052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O6-Methylguanine-DNA methyltransferase is a novel negative effector of invasion in glioblastoma multiforme.
    Chahal M; Abdulkarim B; Xu Y; Guiot MC; Easaw JC; Stifani N; Sabri S
    Mol Cancer Ther; 2012 Nov; 11(11):2440-50. PubMed ID: 22986464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression analysis of all protease genes reveals cathepsin K to be overexpressed in glioblastoma.
    Verbovšek U; Motaln H; Rotter A; Atai NA; Gruden K; Van Noorden CJ; Lah TT
    PLoS One; 2014; 9(10):e111819. PubMed ID: 25356585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes.
    Gulluoglu S; Tuysuz EC; Sahin M; Kuskucu A; Kaan Yaltirik C; Ture U; Kucukkaraduman B; Akbar MW; Gure AO; Bayrak OF; Dalan AB
    Brain Res; 2018 Dec; 1700():199-210. PubMed ID: 30176243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis of potential core genes for glioblastoma.
    Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GBP5 drives malignancy of glioblastoma via the Src/ERK1/2/MMP3 pathway.
    Yu X; Jin J; Zheng Y; Zhu H; Xu H; Ma J; Lan Q; Zhuang Z; Chen CC; Li M
    Cell Death Dis; 2021 Feb; 12(2):203. PubMed ID: 33608513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression.
    Gao YT; Chen XB; Liu HL
    Sci Rep; 2016 Sep; 6():32972. PubMed ID: 27595933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
    Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
    Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.